Sign In

Rx/Reimbursement adult incontinence in
Latvia

Country Report

US$990
Add to cart

Executive Summary

Mar 2019
PROSPECTS
Untapped market potential

Adult incontinence products are reimbursed in Latvia for a set list of diagnosed conditions. Patients diagnosed with these conditions are eligible to a 50% reimbursement from the state for up to three units of adult incontinence.

Reimbursement system seen to be insufficient

The state reimbursement system has been strongly criticised as it overlooks many conditions requiring adult incontinence while it is also generally deemed as insufficient. It is estimated that over 150,000 patients require adult incontinence, while only approximately one in every 10 are eligible for support.

High barriers and low competition

A key factor in Rx/reimbursement adult incontinence is eligibility for state support, which requires each eligible product to be approved and included on a list of medical devices. This requires significant resources on behalf of the manufacturer or distributor and places a significant barrier to entry for newcomers, with the market still being relatively small.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports
Frequently asked questions Our Definitions

Rx/Reimbursement Adult Incontinence in Latvia

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase. 

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Latvia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Latvia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Latvia market research report includes:

  • Analysis of key supply-side and demand trends
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as: 

  • What is the market size of Rx/Reimbursement adult incontinence in Latvia?
  • What are the major brands in Latvia?
  • What are the most important channels for Rx/Reimbursement adult incontinence products?
  • How do light incontinence products perform compared to moderate/heavy incontinence products?
WHY BUY THIS REPORT?
  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our 

Tissue and Hygiene market research database

Rx/Reimbursement Adult Incontinence in Latvia - Category analysis

HEADLINES

PROSPECTS

Untapped market potential
Reimbursement system seen to be insufficient
High barriers and low competition

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2013-2018
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2013-2018
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023

Tissue and Hygiene in Latvia - Industry Overview

EXECUTIVE SUMMARY

Strong economic performance fuels growth
Comfort and convenience key to new product development
International brands lead but private label provides stiff competition
Distribution continues to be dominated by three channels
Cautious optimism regarding the future of tissue and hygiene in Latvia

MARKET INDICATORS

Table 5 Birth Rates 2013-2018
Table 6 Infant Population 2013-2018
Table 7 Female Population by Age 2013-2018
Table 8 Total Population by Age 2013-2018
Table 9 Households 2013-2018
Table 10 Forecast Infant Population 2018-2023
Table 11 Forecast Female Population by Age 2018-2023
Table 12 Forecast Total Population by Age 2018-2023
Table 13 Forecast Households 2018-2023

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2013-2018
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2013-2018
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2014-2018
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2015-2018
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2013-2018
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2013-2018
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2018
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023

SOURCES

Summary 1 Research Sources